By 2025, Continuous Rate Elastomeric Infusion Pumps accounted for 62.09% share of the elastomeric infusion pumps market, reflecting their established role in routine infusion settings where consistent drug delivery is the primary requirement. Their leadership is underpinned by broad clinical familiarity, straightforward operation, and suitability for therapies that do not require frequent adjustment during administration. In the elastomeric infusion pumps market, this dependable fit with standard pain management, antibiotic delivery, and post-acute care workflows helps continuous rate systems retain the largest installed base.

Variable Rate Elastomeric Infusion Pumps are emerging as the fastest-growing product segment in the elastomeric infusion pumps market because they better align with treatment settings that need dosing flexibility without moving to more complex electronic systems. Their growth is being backed by rising demand for infusion approaches that can adapt to changing patient needs across care episodes, especially where clinicians want greater control over flow rate selection while preserving the portability and simplicity associated with elastomeric devices. This practical balance gives variable rate products stronger momentum than fixed-flow alternatives in evolving care delivery models.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals held a 45.83% share of the elastomeric infusion pumps market in 2025, backed by their high procedural volumes and their central role in managing patients who require closely coordinated infusion therapy. The segment remains dominant because hospitals routinely handle a broader mix of surgical, acute, and post-operative cases where elastomeric infusion pumps can be integrated into established pain management and antibiotic administration protocols. Their purchasing scale and continuous patient throughput reinforce hospital leadership across the elastomeric infusion pumps market.

Ambulatory Surgical Centers represent the fastest-growing end-use segment in the elastomeric infusion pumps market as care delivery continues to shift toward efficient outpatient procedures and shorter recovery pathways. Growth in this segment is tied most directly to the need for portable, easy-to-manage infusion solutions that support discharge-oriented treatment models without adding operational complexity. Compared with larger inpatient environments, ambulatory surgical centers benefit more immediately from devices that help streamline post-procedure pain control and therapy continuation, which is driving faster adoption in this setting.